AtaiBeckley (ATAI) EBT Margin (2021 - 2026)
AtaiBeckley (ATAI) recorded quarterly EBT Margin of 3121.8% in Q1 2026, down 84.51% quarter-over-quarter from 1691.9% in Q1 2025, and down 142991.0% on a YoY basis from N/an in Q1 2025.
AtaiBeckley (ATAI) EBT Margin (2021 - 2026) Analysis & Trends
AtaiBeckley has disclosed EBT Margin across 5 years of filings, most recently posting 8139.79% for Q3 2025.
- EBT Margin for Q3 2025 came in at 8139.79%, up 5801771.0% year-over-year; the trailing twelve-month figure through Sep 2025 was 5077.86% (up 3345417.0% YoY), and the FY2024 annual result was 48183.44%, down 3567198.0% from the prior year.
- EBT Margin was 3121.8% for Q1 2026 at AtaiBeckley, down from 1691.9% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 1691.9% in Q1 2025 to a low of 3121.8% in Q1 2026.
- The 5-year median for EBT Margin is 19656.57% (2023), against an average of 54835.77%.
- Across the five-year window, EBT Margin surged 18845718 bps in 2023 and plunged 22475556 bps in 2024, its largest moves.
- AtaiBeckley's EBT Margin stood at 21121.3% in 2021, then sank by 390 bps to 103476.32% in 2022, then gained by 2 bps to 101777.78% in 2023, then slumped by 221 bps to 326533.33% in 2024, then surged by 98 bps to 8139.79% in 2025.
- The last three EBT Margin figures came in at 8139.79% (Q3 2025), 3846.04% (Q2 2025), and 1691.9% (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 6.40% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | AtaiBeckley | 1.45 Bn | 1.45 Bn | - | -3,121.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,121.80% |
| Sep 30, 2025 | -8,139.79% |
| Jun 30, 2025 | -3,846.04% |
| Mar 31, 2025 | -1,691.90% |
| Mar 31, 2025 | -1,691.90% |
| Dec 31, 2024 | -326,533.33% |
| Sep 30, 2024 | -66,157.50% |
| Jun 30, 2024 | -20,907.33% |
| Dec 31, 2023 | -101,777.78% |
| Sep 30, 2023 | 50,398.85% |
| Jun 30, 2023 | -18,405.81% |
| Mar 31, 2023 | -89,610.81% |
| Dec 31, 2022 | -103,476.32% |
| Sep 30, 2022 | -138,058.33% |
| Jun 30, 2022 | -18,121.18% |
| Dec 31, 2021 | -21,121.30% |
| Sep 30, 2021 | -9,952.63% |
| Mar 31, 2021 | 28.94% |